Hear how US Air Force veteran Ben Duncan overcame the symptoms of his essential tremor with Cala TAPS therapy.
Medical Design & Outsourcing profiles Renee Ryan and Kate Rosenbluth for their Women in MedTech series.
New real world evidence demonstrates that Cala TAPS therapy reduced patients’ tremor power with no loss of effect over time. Most patients involved in the study reported improvement in daily activities, such as eating, drinking, texting and writing.
Hear CEO Renee Ryan’s vision for Cala in this interview with the San Francisco Business Times.
Forbes features Cala TAPS therapy and its innovations in bioelectronic medicine in this interview with CEO Renee Ryan.
Chief Commercial Officer Doug Biehn highlights the key actors driving adoption of digital health in his contributed article with MedTech Innovation News.
Doug Biehn, our chief commercial officer, shares his predictions on the future of wearables.
US Air Force veteran Ben Duncan shares his experience navigating essential tremor with the Dallas Observer.
Technology Networks spoke to Renee Ryan, Cala Health’s CEO, to learn more about bioelectronic medicine and its development. In this interview, Renee also discusses the history of bioelectronic medicine and her thoughts on where the field could be headed.